Trial Profile
A Single-Dose, Randomized, Double Blind, Placebo and Active Controlled Cross-Over Study to Evaluate the Abuse Potential of Three Doses of GRT0151Y in Adult Non-dependent Recreational Opiate Users
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2018
Price :
$35
*
At a glance
- Drugs Axomadol (Primary) ; Hydromorphone
- Indications Acute pain
- Focus Adverse reactions
- 14 Dec 2018 New trial record